Evidence map›Paper›PMID 34223923›Full record

ArticleCurrent microbiology2021

Multicentric Analysis of Erythromycin Resistance Determinants in Invasive Streptococcus pneumoniae; Associated Serotypes and Sequence Types in India.

Rosemol Varghese, Jones Lionel Daniel, Ayyanraj Neeravi, Pavithra Baskar, Anand Manoharan, Balasubramanian Sundaram, Vikas Manchanda, Karnika Saigal, Binesh Lal Yesudhasan, Balaji Veeraraghavan

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Current microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Human vaccines & immunotherapeutics · 2025
    Review
  3. Article
  4. Article
  5. Increase of Macrolide-Resistance inFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Rosemol VargheseDepartment of Clinical Microbiology, Christian Medical College, Vellore, 632004, TN, India.
Jones Lionel DanielDepartment of Clinical Microbiology, Christian Medical College, Vellore, 632004, TN, India.
Ayyanraj NeeraviDepartment of Clinical Microbiology, Christian Medical College, Vellore, 632004, TN, India.
Pavithra BaskarDepartment of Clinical Microbiology, Christian Medical College, Vellore, 632004, TN, India.
Anand ManoharanThe CHILDS Trust Medical Research Foundation, Chennai, TN, India.
Balasubramanian SundaramKanchi Kamakoti CHILDS Trust Hospital, Chennai, TN, India.
Vikas ManchandaDepartment of Microbiology, Maulana Azad Medical College, New Delhi, Delhi, India.
Karnika SaigalDepartment of Microbiology, Chacha Nehru Bal Chikitsalaya, New Delhi, Delhi, India.
Binesh Lal YesudhasanDepartment of Clinical Microbiology, Christian Medical College, Vellore, 632004, TN, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College, Vellore, 632004, TN, India. vbalaji@cmcvellore.ac.in.
Christian Medical College & Hospital · INChacha Nehru Bal Chikitsalaya · INKanchi Kamakoti CHILDS Trust Hospital · INMaulana Azad Medical College · INMedical Research Foundation · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae is the major cause of childhood pneumonia and related deaths in India. Widespread use of erythromycin for the treatment of pneumonia has led to the emergence of erythromycin resistance. Despite this increase in erythromycin resistance, there are very little data on resistance determinants from India. Hence, we aimed to perform the molecular characterization of erythromycin-resistant invasive pneumococcal isolates in India. In this study, 250 erythromycin-resistant invasive isolates obtained from four Indian hospitals between 2014 and 2019 were included. The isolates were reconfirmed by standard CDC protocols, followed by detection of erm(B), mef(A/E) genes, and screening for mutations in 23S rRNA, ribosomal proteins L4 and L22. Among the 250 erythromycin-resistant isolates, 46% (n = 114) and 35% (n = 87) carried the mef(A/E) gene and erm(B) gene, respectively; both genes were present in 8% (n = 20) of the isolates and 12% (n = 29) of the studied strains did not bear any of them. The major mutations associated with erythromycin resistance in 23S rRNA, such as A2060C, A2061G, and C2613G, were absent. The predominant serotypes were 19F, 14, 23F, 6A, 6B, 19A, and 9V. The major clonal complexes were CC320, followed by CC230 and CC63. The predominant gene was mef(A/E), and most of the serotypes were PCV13 (54%). This study contributes to the baseline understanding of the erythromycin resistance determinants associated with the serotypes and sequence types (ST) of Indian invasive S. pneumoniae.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial AgentsDrug Resistance, BacterialErythromycinHumansIndiaMicrobial Sensitivity TestsSerogroupSerotypingAnti-Bacterial AgentsErythromycin

Identifiers

PMID34223923
OpenAlexW3179046984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.